• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Cutaneous Signs of Vascular Disorders: Cholesterol Emboli

Article

Painful blue toes developed in a 72-year-old woman with coronary artery andperipheral vascular disease after she underwent angiography.

Painful blue toes developed in a 72-year-old woman with coronary artery andperipheral vascular disease after she underwent angiography.Cholesterol emboli or atheromatous emboli develop when cholesterolplaques are dislodged from the aorta or significantly atherosclerotic proximalvessels after catheterization or the Valsalva maneuver. When the entire aorta isatherosclerotic, the fingers as well as the toes may be affected; systemic complications--including stroke, renal failure, pancreatitis, and GI bleeding--mayalso occur. Associated cutaneous findings may include livedo reticularis of thelegs, purpura of the soles and lateral feet, and ulceration and gangrene. A skinbiopsy specimen shows cholesterol crystals within small arterial vessels.The differential diagnosis of blue toes includes emboli from the heart, collagenvascular disease, primary Raynaud phenomenon, thrombocytosis, polycythemia,vasculitis, cryoglobulinemia, macroglobulinemia, and antiphospholipid syndrome.This patient had a concomitant and unrelated morbilliform drug reactionto furosemide affecting the trunk and extremities, including the dorsal feet.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.